Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
64Cu-DOTA-Trastuzumab Imaging in HER2+ Breast Cancer With Brain Metastasis
NCT05376878Phase 4Recruiting
- Sponsor
- City of Hope
- Start
- Dec 2022
- Primary completion
- Apr 2027
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of 64Cu-DOTA-trastuzumab in breast cancer, sponsored by City of Hope. Started Dec 2022; status: recruiting.
02
Drugs
64Cu-DOTA-trastuzumab
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT05376878.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05376878.